高级检索
    葛艳, 张秀智, 董玲, 王爽, 郑小莉. 附睾蛋白4在卵巢肿瘤中的表达及其与卵巢癌预后生存期的关系[J]. 徐州医科大学学报, 2020, 40(12): 882-886. DOI: 10.3969/j.issn.2096-3882.2020.12.005
    引用本文: 葛艳, 张秀智, 董玲, 王爽, 郑小莉. 附睾蛋白4在卵巢肿瘤中的表达及其与卵巢癌预后生存期的关系[J]. 徐州医科大学学报, 2020, 40(12): 882-886. DOI: 10.3969/j.issn.2096-3882.2020.12.005
    ex<x>pression of HE4 in Patients with Different Pathological Ovarian Lesions and Its Relationship with Prognosis and Survival of EOC[J]. Journal of Xuzhou Medical University, 2020, 40(12): 882-886. DOI: 10.3969/j.issn.2096-3882.2020.12.005
    Citation: ex<x>pression of HE4 in Patients with Different Pathological Ovarian Lesions and Its Relationship with Prognosis and Survival of EOC[J]. Journal of Xuzhou Medical University, 2020, 40(12): 882-886. DOI: 10.3969/j.issn.2096-3882.2020.12.005

    附睾蛋白4在卵巢肿瘤中的表达及其与卵巢癌预后生存期的关系

    ex<x>pression of HE4 in Patients with Different Pathological Ovarian Lesions and Its Relationship with Prognosis and Survival of EOC

    • 摘要: 目的 探究人附睾蛋白4(HE4)在卵巢肿瘤中的表达及其与卵巢癌(EOC)预后生存期的关系.方法选取2015年1月—2017年7月于徐州医科大学附属徐州市立医院确诊的26例卵巢良性肿瘤(A组)、20例卵巢癌(EOC)(B组)、25例卵巢巧克力囊肿(C组)、25例卵巢交界性肿瘤患者(D组)作为研究对象,检测各组血清HE4水平,绘制ROC曲线确定HE4预测EOC生存时间的截断值;采用Kaplan-Meier法和Log-rank法分析年龄、肿瘤分级、肿瘤类型、肿瘤分期、肿瘤转移、分化程度、HE4水平与EOC患者预后关系.结果B组HE4水平高于其他组(P<0.05);肿瘤分级、肿瘤分期、肿瘤转移、HE4水平是影响EOC患者预后危险因素(P<0.05);HE4低表达患者生存期(OS)、无进展生存时间(PFS)高于HE4高表达患者(P<0.05).结论HE4在不同类型卵巢肿瘤组织中表达水平不同,对EOC患者早诊断、早治疗及预后等方面具有很好的评估参考价值.

       

      Abstract: ob<x>jective To investigate the ex<x>pression of human epididymal protein 4 (HE4) in patients with different pathological ovarian lesions and its relationship with prognosis and survival of epithelial ovarian cancer (EOC). Methods 26 cases of ovarian benign tumors, 20 cases of EOCs, 25 cases of chocolate cysts, and 25 cases of other tumor-like lesions diagnosed in our hospital from January 2015to July 20 17 were set as group A, B, C, and D, respectively. The serum HE4 levels in each group were detected and its differential diagnostic value for different ovarian lesions was determined. C orrelation between HE4 ex<x>pression and clinicopathological features and prognosis of EOC patients was determined. Results HE4 level was the highest in group B , followed by group A, group C and group D, with statistic difference (P<0.05). Tumor grade, stage, me<x>tastasis and HE4 level were independent risk factors affecting the prognosis of EOC patients (P<0.05). OS and PFS in patients with low ex<x>pression of HE4 were higher than those with high ex<x>pression of HE4 (P<0.05). Conclusion HE4 is expressed at different levels in different pathological ovarian lesions, and its level is correlated with tumor grade, tumor stage, tumor me<x>tastasis and prognosis of EOC patients, which can provide reference basis for early diagnosis and treatment and prognosis assessment of EOC patients.

       

    /

    返回文章
    返回